Novel Antibody Targets Rheumatoid Arthritis And Inflammatory Bowel Disease
Researchers have shown that a novel antibody generated to target an 'essential amino acid sequence’ of both interleukin-17A and F has greater activity and potentially fewer side effects than existing biological therapies for conditions such as as rhe
Francesco Maione Asif Iqbal University Of Naples Federico Head Of Immunopharma Lab University Of Birmingham Rheumatic Diseases
Source: indiaeducationdiary.in